Market Cap: $1.05B
CI
Castle Biosciences, Inc.
CSTL
NASDAQ (NASDAQ Global Market)USD
Market Cap: $1.05B
Castle Biosciences, Inc. (Ticker: CSTL), a leading diagnostics company focused on innovative health solutions, celebrates the recognition of its Chief Financial Officer, Frank Stokes, as a recipient o…
Castle Biosciences, Inc. (Ticker: CSTL), a diagnostics company focused on improving health through innovative testing, announces a significant development in enhancing employee incentives. The company…
Castle Biosciences, Inc. (Ticker: CSTL) celebrates a major achievement with over 100,000 clinical test orders for its TissueCypher® Barrett's Esophagus Test. Precision Medicine Breakthrough As of June…
Castle Biosciences, Inc. (Ticker: CSTL) has gained a significant accolade, winning the 'Genomics Innovation Award' at the 10th annual MedTech Breakthrough Awards for its AdvanceAD-Tx test. This award…
Castle Biosciences Strengthens Diagnostic Innovations at AAD Annual Meeting Castle Biosciences, Inc. is making significant advancements in the field of dermatology by presenting compelling research fi…
Transforming Melanoma Management: Castle Biosciences Unveils Key Findings at AAD Annual Meeting At the 2026 American Academy of Dermatology (AAD) Annual Meeting, Castle Biosciences, Inc. demonstrates…
Castle Biosciences Enhances Growth Through Innovation Amid Financial Hurdles Castle Biosciences announces its Q4 earnings results, highlighting a substantial rise in revenue that underscores the compa…
Castle Biosciences Prepares for Key Quarterly Earnings Report Castle Biosciences Inc. is positioned to unveil its latest quarterly earnings report on February 26, 2026, amidst heightened anticipation…
Castle Biosciences Charts Future Growth Amidst Financial Challenges Castle Biosciences, a company specializing in innovative solutions for skin cancer diagnostics, prepares for its quarterly earnings…
Castle Biosciences: Leveraging Q3 Success to Propel Diagnostics Innovation Castle Biosciences continues to solidify its position in the diagnostics and personalized medicine sector, following a strong…
Castle Biosciences: Advancing Precision Medicine in Oncology Castle Biosciences continues to make significant strides in precision medicine, particularly in the field of oncology. The company speciali…
Castle Biosciences Prepares for Critical Earnings Report Amidst Focus on Innovation in Personalized Medicine Castle Biosciences, a leader in developing innovative diagnostic tests for skin cancer and…
Castle Biosciences Expands Diagnostic Portfolio with New Melanoma Test Castle Biosciences, a leading provider of innovative diagnostic tests for skin cancer, announces the launch of its latest product…
Castle Biosciences Advances in Cancer Diagnostics with Innovative Strategies Castle Biosciences, a leader in skin cancer diagnostic solutions, continues to enhance its portfolio with cutting-edge tech…
Castle Biosciences: Pioneering Diagnostic Solutions in Dermatology Castle Biosciences (CSTL) stands at the forefront of innovation in dermatological diagnostics, a sector increasingly driven by the de…
Castle Biosciences Advances Skin Cancer Management with Innovative GEP Testing Presentations Castle Biosciences, Inc., a company headquartered in Friendswood, Texas, prepares to showcase its groundbre…
Castle Biosciences Advances Skin Cancer Management at Upcoming Conference Castle Biosciences, Inc., a Texas-based company specializing in innovative testing for skin cancers, prepares to present signi…
Castle Biosciences: Advancing Patient Care Through Innovative Diagnostics Castle Biosciences, Inc. is at the forefront of transforming disease management with a strong focus on innovative diagnostic t…
Castle Biosciences: Pioneering Innovations in Patient-Centric Diagnostics Castle Biosciences, Inc., a leading diagnostics company, focuses on developing innovative tests designed to enhance patient ca…
Castle Biosciences Reports Impressive Fourth Quarter and Year-End Performance Castle Biosciences, Inc., a Texas-based leader in innovative diagnostic solutions, showcases significant growth in its tes…
Castle Biosciences Reports Significant Growth in Testing Services Amidst Market Challenges Castle Biosciences, Inc., based in Friendswood, Texas, showcases a robust performance in its preliminary resu…
Castle Biosciences Achieves Milestone with TissueCypher Approval in New York Castle Biosciences, Inc., a leading precision medicine company based in Friendswood, Texas, celebrates a significant achiev…
Castle Biosciences Achieves Key Milestone with TissueCypher Test Approval Castle Biosciences, Inc., based in Friendswood, Texas, announces a significant advancement in precision medicine with the full…
Castle Biosciences Advances Precision Medicine for Atopic Dermatitis Patients Castle Biosciences, Inc., headquartered in Friendswood, Texas, is making strides in developing a novel diagnostic test aim…
Castle Biosciences Advances Targeted Treatment for Atopic Dermatitis Castle Biosciences, Inc., a Texas-based leader in dermatological diagnostics, is making strides in the development of a novel test…